Drug-induced hypersensitivity syndrome and viral reactivation

Drug Hypersensitivity

Volumn , Issue , 2007, Pages 251-266

  Shiohara Dr , Tetsuo ^a   Takahashi, Ryo ^a   Kano, Yoko ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882117592     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000104205     Document Type: Chapter

References (57)

1. Merritt HH, Putnam TJ: Sodium diphenylhydantoinate in the treatment of convulsive disorders. JAMA 1938;111: 1068-1073.
2. Chaiken BH, Goldberg BI, Segal JP: Dilantin hypersensitivity: report of a case of hepatitis with jaundice, pyrexia, and exfoliative dermatitis. N Engl J Med 1950;242: 897-898.
3. Shear NH, Spielberg SP: Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 1988;82: 1826-1832.
4. Bocquet H, Bagot M, Roujeau JC: Drug induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996;15: 250-257.
5. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T: Human herpesvirus 6 infection as a risk factor for the development of severe drug induced hyper sensitivity syndrome. Arch Dermatol 1998;134: 1108-1112.
6. Shiohara T, Inaoka M, Kano Y: Drug induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 2006;55: 1-8.
7. Tohyama H, Yahata Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K, Hashimoto K: Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6.Arch Dermatol 1998;134: 1113-1117.
8. Hashimoto K, Yasukawa M, Tohyama M: Human herpesvirus 6 and drug allergy. Curr Opin Allergy Clin Immunol 2003;3: 255-260.
9. Kano Y, Inaoka M, Shiohara T: Association between anticonvulsant hypersensitivity syndrome and human herpes virus 6 reactivation and hypogamma globulinemia. Arch Dermatol 2004;140: 183-188.
10. Kano Y, Hirahara K, Sakuma K, Shiohara T: Several herpesviruses can reactivate in a severe drug induced multi-organ reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 2006;155: 301-306.
11. Gennis MA, Vemuri R, Burns EA, Hill JV, Miller MA, Spielberg SP: Familiar occurrence of hypersensitivity to phe-nytoin. Am J Med 1991;91: 631-634.
12. Vittorio CC, Muglia JJ: Anticonvulsant hypersensitivity syndrome. Arch In-tern Med 1995;155: 2285-2290.
13. Gaffey CM, Chun B, Harvey JC, Manz HJ: Phenytoin-induced systemic granulomatous vasculitis. Arch Pathol Lab Med 1986;110: 131-135.
14. Taylor JW, Stein MN, Murphy MJ, Mitros FA: Cholestatic liver dysfunction after long-term phenytoin therapy. Arch Neurol 1984;41: 500-501.
15. Pezzimenti JF, Hahn AL: Anicteric hepatitis induced by diphenylhydantoin. Arch Intern Med 1970;125: 118-120.
16. Silverman AK, Fairley J, Wong RC: Cutaneous and immunologic reactions to phenytoin. J Am Acad Dermatol 1988;18: 721-741.
17. Chan HL, Stern RS, Arndt KA, Langlois J, Jick SS, Jick H, Walker AM: The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population based study with particular reference to reac-tions caused by drugs among outpatients. Arch Dermatol 1990;126: 43-47.
18. Stanley J, Fallon-Pellicci V: Phenytoin hypersensitivity reaction. Arch Derma-tol 1978;114: 1350-1353.
19. Peyriére H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac J-P, Hillaire-Buys D; Network of the French Pharmacovigilance Centers: Variability in the clinical pattern of cutaneous side effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2006;155: 422-428.
20. Horneff G, Lenard HG, Wahn V: Severe adverse reaction to carbamazepine: Significance of humoral and cellular reactions to the drug. Neuropediatrics 1992;23: 272-275.
21. Gropper AL: Diphenylhydantoin sensitivity: report of fatal case with hepatitis and exfoliative dermatitis. N Engl J Med 1956;254: 522-523.
22. Handfield-Jones SE, Jenkins RE, Whittaker SJ, Besse CP, McGibbon DH: The anticonvulsant hypersensitivity syndrome. Br J Dermatol 1993;129: 175-177.
23. Kleier RS, Breneman DL, Boiko S: Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome. Arch Dermatol 1991;127: 1361-1364.
24. Hogg RJ, Sawyer M, Hecox K, Eigenbrodt E: Carbamazepine induced acute tubulointestinal nephritis. J Pediatr 1981;83: 830-832.
25. Imai H, Nakamoto Y, Hirokawa M, Akihama T, Miura A: Carbamazepine induced granulomatous necrotizing angiitis with acute renal failure. Nephron 1989;51: 405-408.
26. Alldredge BK, Knutsen AP, Ferriero D: Antiepileptic drug hypersensitivity syndrome: in vitro and clinical observations. Pediatr Neurol 1994;10: 169-171.
27. Puller H, Wright N, Murdoch JM: Hypersensitivity reactions to antibacterial drugs in infectious mononucleosis. Lancet 1967;2: 1176-1178.
28. Patel M: Skin rash with infectious mononucleosis and ampicillin. Pediatrics 1967;40: 910-911.
29. Yasukawa K, Matsumura T, Sato-Mat-sumura KC, Takahashi T, Fujioka Y, Kobayashi H, Shimizu H: Kikuchi's disease and the skin: case report and review of the literature. Br J Dermatol 2001;144: 885-889.
30. Dominguez DC, Torres ML, Antony S: Is human herpesvirus 6 linked to Kiku-chi-Fujimoto disease? The importance of consistent molecular and serologic analysis. South Med J 2003;96: 226-233.
31. Hudnall SD: Kikuchi Fujimoto disease. Is Epstein Barr virus the culprit? Am J Clin Pathol 2000;1113: 761-764.
32. Descamps V, Mahe E, Houhou N, Abramowitz L, Rozenberg F, Ranger Rogez S, Crickx B: Drug induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol 2003;148: 1032-1034.
33. Aihara M, Sugita Y, Takahashi S, Nagatani T, Arata S, Takeuchi K, Ikezawa Z: Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus. Br J Dermatol 2001;144: 1231-1234.
34. Wu Y, Sanderson JP, Farrell J, Drummond NS, Hanson A, Bowkett E, Berry N, Stachulski AV, Clarke SE, Pichler WJ, Pirmohamed M, Park BK, Naisbitt DJ: Activation of T cells by carbamazepine and carbamazepine metabolites. J Allergy Clin Immunol 2006;118: 233-241.
35. Naisbitt DJ, Farrell J, Wong G, Depta JP, Dodd CC, Hopkins JE, Gibney CA, Chadwick DW, Pichler WJ, Pirmohamed M, Park BK: Characterization of drug specific T cells in lamotrigine hypersensitivity. J Allergy Clin Immunol 2003; 111: 1393-1403.
36. Katsafanas GC, Schirmer EC, Wyatt LS, Frenkel N: In vitro activation of human herpesviruses 6 and 7 from latency. Proc Natl Acad Sci USA 1996; 93: 9788-9792.
37. Maeda Y, Teshima T, Yamada M, Shinagawa K, Nakao S, Ohno Y, Kojima K, Hara M, Nagafuji K, Hayashi S, Fukuda S, Sawada H, Matsue K, Takenaka K, Isimura F, Ikeda K, Niiya K, Harada M: Monitoring of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation. Br J Haematol 1999; 105: 295-302.
38. Maeda Y, Teshima T, Yamada M, Harada M: Reactivation of human herpes viruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation. Leuk Lymphoma 2000; 39: 229-239.
39. Dockrell DH, Paya CV: Human herpes-virus-6 and -7 in transplantation. Rev Med Virol 2001; 11: 23-36.
40. Appleton AL, Sviland L: Pathogenesis of GVHD: role of herpes viruses. Bone Marrow Transplant 1993; 11: 349-355.
41. Ferrara JLM, Levy R, Chao NJ: Patho-physiologic mechanisms of acute graft-vs.-host disease. Biol Blood Marrow Transplant 1999; 5: 347-356.
42. Singh N, Carrigan DR: Human herpes-virus-6 in transplantation: an emerging pathogen. Ann Intern Med 1996; 124: 1065-1071.
43. Levy JA: Three new human herpesviruses (HHV-6, 7, and 8). Lancet 1997; 349: 558-562.
44. Keever CA, Small TN, Flomenberg N, Heller G, Pekle K, Black P, Pecora A, Gillio A, Kernan NA, O'Reilly RJ: Im-mune reconstitution following bone marrow transplantation: Comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 1989; 73: 1340-1350.
45. Burrows SR, Khanna R, Burrows JM, Moss PJ: An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implication for graft-versus-host disease. J Exp Med 1994; 179: 1155-1161.
46. Burrows SR, Silins SL, Moss DJ, Khanna R, Misko IS, Argaet VP: T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigens. J Exp Med 1995; 182: 1703-1715.
47. Burrows SR, Silins SL, Khanna R, Burrow JM, Rischmueller M, Mc Cluskey J, Moss DJ: Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leuko-cyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur J Immunol 1997; 27: 1726-1736.
48. Sharrock CE, Kaminski E, Man S: Limiting dilution analysis of human T cells: a useful clinical tool. Immunol Today 1990; 11: 281-286.
49. Borysiewicz LK, Graham S, Hickling JK, Mason PD, Sissons JG: Human cytomegalovirus specific cytotoxic T cells: their precursor frequency and stage specificity. Eur J Immunol 1988; 18: 269-275.
50. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT: Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004; 428: 486.
51. Pichler WJ, Tilch J: The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004; 59: 809-820.
52. Hirsch HH, Kaufmann G, Sendi P, Battegy M: Immune reconstitution in HIV-infected patients. Clin Infect Dis 2004; 38: 1158-1166.
53. Cooney EL: Clinical indication of immune restoration following highly active antiretroviral therapy. Clin Infect Dis 2002; 34: 224-233.
54. Rodriguez-Rosado R, Soriano V, Donna C, Gonzales-Lahoz J: Opportunistic infections shortly after beginning highly active antiretroviral therapy. Antivir Ther 1998; 3: 229-231.
55. Tubiana TSLi, Katalama C, Calvez V, Mohand Hait, Autran B: Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998; 351: 1682-1686.
56. McComsey GA, Whalen CC, Mawhorter SD, Asaad R, Valdeg H, Patki AH, Klaumunzner J, Gopalakrishna KV, Calabrese LH, Lederman MM: Placebo-controlled trial of prednisone in advanced HIV infection. AIDS 2001; 15: 321-327.
57. Chiou CC, Chung WH, Hung SL, Yang LC, Hong HS: Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection. J Am Acad Dermatol 2006; 54(suppl):S14-S17.